Free Circulating and Extracellular Vesicles-Derived microRNA as Prognostic Biomarkers in Resected Early-Stage NSCLC: RESTING Study Results
Journal of Thoracic Oncology(2023)
摘要
About 20% of non-small cell lung cancer (NSCLC) are diagnosed at an early stage, allowing an effective pulmonary resection, but many patients still experience disease recurrence. Thus, biomarkers able to stratify patients with a different prognosis are needed. This study aims to investigate 1) the prognostic potential of free circulating (FC) and extracellular vesicles (EVs)-derived microRNA (miRNAs), and 2) the added of prognostic capacity of the combination of biomarkers and known prognostic factors (PFs).
更多查看译文
关键词
miRNA,prognosis,early-stage NSCLC
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要